Trials / Completed
CompletedNCT03765944
Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets
A Single Dose, Randomized, Open-label, 2-Period, 2-way Crossover, Bioequivalence Study of Sirolimus Granules and Sirolimus Tablets in Japanese Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Nobelpharma · Industry
- Sex
- All
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the bioequivalece of NPC-12 granules in compare with NPC-12T tablets in Japanese healthy Adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sirolimus | SIngle administration under fasted condition |
Timeline
- Start date
- 2018-12-05
- Primary completion
- 2018-12-29
- Completion
- 2018-12-29
- First posted
- 2018-12-05
- Last updated
- 2019-02-25
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03765944. Inclusion in this directory is not an endorsement.